Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models.

Bonsi P, Ponterio G, Vanni V, Tassone A, Sciamanna G, Migliarini S, Martella G, Meringolo M, Dehay B, Doudnikoff E, Zachariou V, Goodchild RE, Mercuri NB, D'Amelio M, Pasqualetti M, Bezard E, Pisani A.

EMBO Mol Med. 2019 Jan;11(1). pii: e9283. doi: 10.15252/emmm.201809283.

2.

Bottom-up processing of curvilinear visual features is sufficient for animate/inanimate object categorization.

Zachariou V, Del Giacco AC, Ungerleider LG, Yue X.

J Vis. 2018 Nov 1;18(12):3. doi: 10.1167/18.12.3.

3.

Striatal Rgs4 regulates feeding and susceptibility to diet-induced obesity.

Michaelides M, Miller ML, Egervari G, Primeaux SD, Gomez JL, Ellis RJ, Landry JA, Szutorisz H, Hoffman AF, Lupica CR, Loos RJF, Thanos PK, Bray GA, Neumaier JF, Zachariou V, Wang GJ, Volkow ND, Hurd YL.

Mol Psychiatry. 2018 Jun 28. doi: 10.1038/s41380-018-0120-7. [Epub ahead of print]

4.

The Fusiform and Occipital Face Areas Can Process a Nonface Category Equivalently to Faces.

Zachariou V, Safiullah ZN, Ungerleider LG.

J Cogn Neurosci. 2018 Oct;30(10):1499-1516. doi: 10.1162/jocn_a_01288. Epub 2018 Jun 7.

PMID:
29877768
5.

Suppression of RGSz1 function optimizes the actions of opioid analgesics by mechanisms that involve the Wnt/β-catenin pathway.

Gaspari S, Purushothaman I, Cogliani V, Sakloth F, Neve RL, Howland D, Ring RH, Ross EM, Shen L, Zachariou V.

Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):E2085-E2094. doi: 10.1073/pnas.1707887115. Epub 2018 Feb 12.

6.

Effective Attenuation of Adenosine A1R Signaling by Neurabin Requires Oligomerization of Neurabin.

Chen Y, Booth C, Wang H, Wang RX, Terzi D, Zachariou V, Jiao K, Zhang J, Wang Q.

Mol Pharmacol. 2017 Dec;92(6):630-639. doi: 10.1124/mol.117.109462. Epub 2017 Sep 27.

7.

Endogenous visuospatial attention increases visual awareness independent of visual discrimination sensitivity.

Vernet M, Japee S, Lokey S, Ahmed S, Zachariou V, Ungerleider LG.

Neuropsychologia. 2017 Aug 12. pii: S0028-3932(17)30309-3. doi: 10.1016/j.neuropsychologia.2017.08.015. [Epub ahead of print]

8.

Brain-Derived Neurotrophic Factor in the Mesolimbic Reward Circuitry Mediates Nociception in Chronic Neuropathic Pain.

Zhang H, Qian YL, Li C, Liu D, Wang L, Wang XY, Liu MJ, Liu H, Zhang S, Guo XY, Yang JX, Ding HL, Koo JW, Mouzon E, Deisseroth K, Nestler EJ, Zachariou V, Han MH, Cao JL.

Biol Psychiatry. 2017 Oct 15;82(8):608-618. doi: 10.1016/j.biopsych.2017.02.1180. Epub 2017 Mar 1.

9.

Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depression.

Descalzi G, Mitsi V, Purushothaman I, Gaspari S, Avrampou K, Loh YE, Shen L, Zachariou V.

Sci Signal. 2017 Mar 21;10(471). pii: eaaj1549. doi: 10.1126/scisignal.aaj1549.

10.

RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States.

Gaspari S, Cogliani V, Manouras L, Anderson EM, Mitsi V, Avrampou K, Carr FB, Zachariou V.

Neuropsychopharmacology. 2017 Jun;42(7):1548-1556. doi: 10.1038/npp.2017.4. Epub 2017 Jan 11.

11.

Modulation of pain, nociception, and analgesia by the brain reward center.

Mitsi V, Zachariou V.

Neuroscience. 2016 Dec 3;338:81-92. doi: 10.1016/j.neuroscience.2016.05.017. Epub 2016 May 14. Review.

12.

Spatial Mechanisms within the Dorsal Visual Pathway Contribute to the Configural Processing of Faces.

Zachariou V, Nikas CV, Safiullah ZN, Gotts SJ, Ungerleider LG.

Cereb Cortex. 2017 Aug 1;27(8):4124-4138. doi: 10.1093/cercor/bhw224.

13.

Evaluation of multi-echo ICA denoising for task based fMRI studies: Block designs, rapid event-related designs, and cardiac-gated fMRI.

Gonzalez-Castillo J, Panwar P, Buchanan LC, Caballero-Gaudes C, Handwerker DA, Jangraw DC, Zachariou V, Inati S, Roopchansingh V, Derbyshire JA, Bandettini PA.

Neuroimage. 2016 Nov 1;141:452-468. doi: 10.1016/j.neuroimage.2016.07.049. Epub 2016 Jul 27.

14.

Constance E. Lieber, Theodore R. Stanley, and the Enduring Impact of Philanthropy on Psychiatry Research.

Krystal JH, Abi-Dargham A, Akbarian S, Arnsten AFT, Barch DM, Bearden CE, Braff DL, Brown ES, Bullmore ET, Carlezon WA Jr, Carter CS, Cook EH Jr, Daskalakis ZJ, DiLeone RJ, Duman RS, Grace AA, Hariri AR, Harrison PJ, Hiroi N, Kenny PJ, Kleinman JE, Krystal AD, Lewis DA, Lipska BK, Marder SR, Mason GF, Mathalon DH, McClung CA, McDougle CJ, McIntosh AM, McMahon FJ, Mirnics K, Monteggia LM, Narendran R, Nestler EJ, Neumeister A, O'Donovan MC, Öngür D, Pariante CM, Paulus MP, Pearlson G, Phillips ML, Pine DS, Pizzagalli DA, Pletnikov MV, Ragland JD, Rapoport JL, Ressler KJ, Russo SJ, Sanacora G, Sawa A, Schatzberg AF, Shaham Y, Shamay-Tsoory SG, Sklar P, State MW, Stein MB, Strakowski SM, Taylor SF, Turecki G, Turetsky BI, Weissman MM, Zachariou V, Zarate CA Jr, Zubieta JK.

Biol Psychiatry. 2016 Jul 15;80(2):84-86. doi: 10.1016/j.biopsych.2016.05.004. No abstract available.

15.

Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior.

Gacias M, Gaspari S, Santos PM, Tamburini S, Andrade M, Zhang F, Shen N, Tolstikov V, Kiebish MA, Dupree JL, Zachariou V, Clemente JC, Casaccia P.

Elife. 2016 Apr 20;5. pii: e13442. doi: 10.7554/eLife.13442.

16.

Common Dorsal Stream Substrates for the Mapping of Surface Texture to Object Parts and Visual Spatial Processing.

Zachariou V, Nikas CV, Safiullah ZN, Behrmann M, Klatzky R, Ungerleider LG.

J Cogn Neurosci. 2015 Dec;27(12):2442-61. doi: 10.1162/jocn_a_00871. Epub 2015 Sep 11.

PMID:
26359538
17.

RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.

Mitsi V, Terzi D, Purushothaman I, Manouras L, Gaspari S, Neve RL, Stratinaki M, Feng J, Shen L, Zachariou V.

Proc Natl Acad Sci U S A. 2015 Sep 8;112(36):E5088-97. doi: 10.1073/pnas.1504283112. Epub 2015 Aug 24.

18.

Epigenetic mechanisms of chronic pain.

Descalzi G, Ikegami D, Ushijima T, Nestler EJ, Zachariou V, Narita M.

Trends Neurosci. 2015 Apr;38(4):237-46. doi: 10.1016/j.tins.2015.02.001. Epub 2015 Mar 9. Review. Erratum in: Trends Neurosci. 2015 Sep;38(9):579.

19.

Rodent models of treatment-resistant depression.

Caldarone BJ, Zachariou V, King SL.

Eur J Pharmacol. 2015 Apr 15;753:51-65. doi: 10.1016/j.ejphar.2014.10.063. Epub 2014 Nov 21. Review.

20.

Size precedes view: developmental emergence of invariant object representations in lateral occipital complex.

Nishimura M, Scherf KS, Zachariou V, Tarr MJ, Behrmann M.

J Cogn Neurosci. 2015 Mar;27(3):474-91. doi: 10.1162/jocn_a_00720. Epub 2014 Sep 22.

PMID:
25244115
21.

RGS9-2 modulates sensory and mood related symptoms of neuropathic pain.

Terzi D, Gaspari S, Manouras L, Descalzi G, Mitsi V, Zachariou V.

Neurobiol Learn Mem. 2014 Nov;115:43-8. doi: 10.1016/j.nlm.2014.08.005. Epub 2014 Aug 19.

22.

Nociception and pain: lessons from optogenetics.

Carr FB, Zachariou V.

Front Behav Neurosci. 2014 Mar 25;8:69. doi: 10.3389/fnbeh.2014.00069. eCollection 2014. Review.

23.

Nucleus accumbens-specific interventions in RGS9-2 activity modulate responses to morphine.

Gaspari S, Papachatzaki MM, Koo JW, Carr FB, Tsimpanouli ME, Stergiou E, Bagot RC, Ferguson D, Mouzon E, Chakravarty S, Deisseroth K, Lobo MK, Zachariou V.

Neuropsychopharmacology. 2014 Jul;39(8):1968-77. doi: 10.1038/npp.2014.45. Epub 2014 Feb 24.

24.

Ventral and dorsal visual stream contributions to the perception of object shape and object location.

Zachariou V, Klatzky R, Behrmann M.

J Cogn Neurosci. 2014 Jan;26(1):189-209. doi: 10.1162/jocn_a_00475. Epub 2013 Sep 3.

25.

Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models.

Stratinaki M, Varidaki A, Mitsi V, Ghose S, Magida J, Dias C, Russo SJ, Vialou V, Caldarone BJ, Tamminga CA, Nestler EJ, Zachariou V.

Proc Natl Acad Sci U S A. 2013 May 14;110(20):8254-9. doi: 10.1073/pnas.1214696110. Epub 2013 Apr 29. Erratum in: Proc Natl Acad Sci U S A. 2013 Jul 9;110(28):11660.

26.

BDNF parabrachio-amygdaloid pathway in morphine-induced analgesia.

Sarhan M, Pawlowski SA, Barthas F, Yalcin I, Kaufling J, Dardente H, Zachariou V, Dileone RJ, Barrot M, Veinante P.

Int J Neuropsychopharmacol. 2013 Aug;16(7):1649-60. doi: 10.1017/S146114571200168X. Epub 2013 Feb 21.

PMID:
23425507
27.

Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens.

Sun H, Maze I, Dietz DM, Scobie KN, Kennedy PJ, Damez-Werno D, Neve RL, Zachariou V, Shen L, Nestler EJ.

J Neurosci. 2012 Nov 28;32(48):17454-64. doi: 10.1523/JNEUROSCI.1357-12.2012.

28.

Association between regulator of G protein signaling 9-2 and body weight.

Waugh JL, Celver J, Sharma M, Dufresne RL, Terzi D, Risch SC, Fairbrother WG, Neve RL, Kane JP, Malloy MJ, Pullinger CR, Gu HF, Tsatsanis C, Hamilton SP, Gold SJ, Zachariou V, Kovoor A.

PLoS One. 2011;6(11):e27984. doi: 10.1371/journal.pone.0027984. Epub 2011 Nov 23.

29.

R7BP modulates opiate analgesia and tolerance but not withdrawal.

Terzi D, Cao Y, Agrimaki I, Martemyanov KA, Zachariou V.

Neuropsychopharmacology. 2012 Mar;37(4):1005-12. doi: 10.1038/npp.2011.284. Epub 2011 Nov 16.

30.

Galanin negatively modulates opiate withdrawal via galanin receptor 1.

Holmes FE, Armenaki A, Iismaa TP, Einstein EB, Shine J, Picciotto MR, Wynick D, Zachariou V.

Psychopharmacology (Berl). 2012 Apr;220(3):619-25. doi: 10.1007/s00213-011-2515-x. Epub 2011 Oct 4.

31.

Gene therapy for psychiatric disorders.

Thome J, Hässler F, Zachariou V.

World J Biol Psychiatry. 2011 Sep;12 Suppl 1:16-8. doi: 10.3109/15622975.2011.601927. Review.

32.

Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens.

Sim-Selley LJ, Cassidy MP, Sparta A, Zachariou V, Nestler EJ, Selley DE.

Neuropharmacology. 2011 Dec;61(8):1470-6. doi: 10.1016/j.neuropharm.2011.08.046. Epub 2011 Sep 3.

33.

RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn.

Papachatzaki MM, Antal Z, Terzi D, Szücs P, Zachariou V, Antal M.

Neurosci Lett. 2011 Aug 21;501(1):31-4. doi: 10.1016/j.neulet.2011.06.033. Epub 2011 Jun 29.

34.

A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia.

Psifogeorgou K, Terzi D, Papachatzaki MM, Varidaki A, Ferguson D, Gold SJ, Zachariou V.

J Neurosci. 2011 Apr 13;31(15):5617-24. doi: 10.1523/JNEUROSCI.4146-10.2011. Erratum in: J Neurosci. 2011 May 18;31(20):7578. Psigfogeorgou, Kassi [corrected to Psifogeorgou, Kassi].

35.

Haloperidol alters circadian clock gene product expression in the mouse brain.

Coogan AN, Papachatzaki MM, Clemens C, Baird A, Donev RM, Joosten J, Zachariou V, Thome J.

World J Biol Psychiatry. 2011 Dec;12(8):638-44. doi: 10.3109/15622975.2010.543149. Epub 2011 Jan 20.

PMID:
21250933
36.

Brain region specific actions of regulator of G protein signaling 4 oppose morphine reward and dependence but promote analgesia.

Han MH, Renthal W, Ring RH, Rahman Z, Psifogeorgou K, Howland D, Birnbaum S, Young K, Neve R, Nestler EJ, Zachariou V.

Biol Psychiatry. 2010 Apr 15;67(8):761-9. doi: 10.1016/j.biopsych.2009.08.041. Epub 2009 Nov 14.

37.

Modulation of opioid receptor function by protein-protein interactions.

Alfaras-Melainis K, Gomes I, Rozenfeld R, Zachariou V, Devi L.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3594-607. Review.

38.

RGS9-2: probing an intracellular modulator of behavior as a drug target.

Traynor JR, Terzi D, Caldarone BJ, Zachariou V.

Trends Pharmacol Sci. 2009 Mar;30(3):105-11. doi: 10.1016/j.tips.2008.11.006. Epub 2009 Feb 9.

39.

Regulators of G protein signaling in neuropsychiatric disorders.

Terzi D, Stergiou E, King SL, Zachariou V.

Prog Mol Biol Transl Sci. 2009;86:299-333. doi: 10.1016/S1877-1173(09)86010-9. Epub 2009 Oct 7. Review.

PMID:
20374720
40.

Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.

Terzi D, Zachariou V.

Biotechnol J. 2008 Dec;3(12):1555-63. doi: 10.1002/biot.200800284. Review.

PMID:
19072910
41.

Calcium-sensitive adenylyl cyclases in depression and anxiety: behavioral and biochemical consequences of isoform targeting.

Krishnan V, Graham A, Mazei-Robison MS, Lagace DC, Kim KS, Birnbaum S, Eisch AJ, Han PL, Storm DR, Zachariou V, Nestler EJ.

Biol Psychiatry. 2008 Aug 15;64(4):336-43. doi: 10.1016/j.biopsych.2008.03.026. Epub 2008 May 12.

42.

Multiple actions of spinophilin regulate mu opioid receptor function.

Charlton JJ, Allen PB, Psifogeorgou K, Chakravarty S, Gomes I, Neve RL, Devi LA, Greengard P, Nestler EJ, Zachariou V.

Neuron. 2008 Apr 24;58(2):238-47. doi: 10.1016/j.neuron.2008.02.006.

43.

Morphine blood levels, dependence, and regulation of hippocampal subgranular zone proliferation rely on administration paradigm.

Fischer SJ, Arguello AA, Charlton JJ, Fuller DC, Zachariou V, Eisch AJ.

Neuroscience. 2008 Feb 19;151(4):1217-24. doi: 10.1016/j.neuroscience.2007.11.035. Epub 2007 Dec 3.

PMID:
18248906
44.

Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies.

Zachariou V, Liu R, LaPlant Q, Xiao G, Renthal W, Chan GC, Storm DR, Aghajanian G, Nestler EJ.

Biol Psychiatry. 2008 Jun 1;63(11):1013-21. doi: 10.1016/j.biopsych.2007.11.021. Epub 2008 Jan 28.

45.

A role of RGS proteins in drug addiction.

Hooks SB, Martemyanov K, Zachariou V.

Biochem Pharmacol. 2008 Jan 1;75(1):76-84. Epub 2007 Aug 11. Review.

PMID:
17880927
46.

RGS9-2 is a negative modulator of mu-opioid receptor function.

Psifogeorgou K, Papakosta P, Russo SJ, Neve RL, Kardassis D, Gold SJ, Zachariou V.

J Neurochem. 2007 Oct;103(2):617-25. Epub 2007 Aug 23.

47.

Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity.

Allen PB, Zachariou V, Svenningsson P, Lepore AC, Centonze D, Costa C, Rossi S, Bender G, Chen G, Feng J, Snyder GL, Bernardi G, Nestler EJ, Yan Z, Calabresi P, Greengard P.

Neuroscience. 2006 Jul 7;140(3):897-911.

PMID:
16600521
48.

An essential role for DeltaFosB in the nucleus accumbens in morphine action.

Zachariou V, Bolanos CA, Selley DE, Theobald D, Cassidy MP, Kelz MB, Shaw-Lutchman T, Berton O, Sim-Selley LJ, Dileone RJ, Kumar A, Nestler EJ.

Nat Neurosci. 2006 Feb;9(2):205-11. Epub 2006 Jan 15.

PMID:
16415864
49.

Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action.

Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ.

Neuropsychopharmacology. 2006 Mar;31(3):555-62.

50.

Supplemental Content

Loading ...
Support Center